文献速递血栓与止血

基于血浆蛋白质组学探讨儿童原发性免疫性血小板减少症的诊断敏感标志物

Study on diagnostic-sensitive markers of primary immune thrombocytopenia in children based on plasma proteomics.
PubMed 文献 · Br J Haematol · 2024-08-27

本研究采用4D-DIA蛋白质组学技术筛选儿童ITP诊断标志物,发现55个差异表达蛋白(43个升高、12个降低),并选取MMP-9和THBS1在50例样本(13例健康对照、15例继发性血小板减少对照、22例ITP患儿)中进行ELISA验证,结果与蛋白质组学一致,ROC曲线提示二者具有诊断价值,但作者认为其作为ITP诊断标志物的潜在作用尚需进一步研究。

要点

  • ITP组较对照组有55个差异表达蛋白(43个升高、12个降低)。
  • ITP患儿血浆MMP-9水平升高、THBS1浓度降低。
  • ROC曲线提示MMP-9和THBS1对ITP诊断具有价值。

核心结论

  • 蛋白质组学有助于识别ITP诊断的敏感生物标志物。
  • 初步筛选出MMP-9和THBS1两个差异表达蛋白,其作为诊断ITP生物标志物的潜在作用尚需进一步研究。

研究设计与样本

  • 研究纳入ITP组和对照组儿童,采用4D-DIA蛋白质组学方法分析蛋白表达。
  • 差异蛋白在包含50例样本的队列中进行ELISA验证,该队列包括13例健康对照、15例继发性血小板减少对照和22例ITP患儿。
  • 采用ROC曲线评估诊断ITP的效果。

主要发现

  • 与对照组相比,ITP组确定55个差异表达蛋白,其中43个升高、12个降低。
  • MMP-9和THBS1显著表达并被选作ELISA验证,验证结果与蛋白质组学检查结果一致。
  • 与对照队列相比,ITP受试者血浆MMP-9水平显著升高、血浆THBS1浓度降低。
  • ROC曲线提示这些生物标志物具有诊断价值。

关键数值与推荐

  • ITP组较对照组有55个差异表达蛋白(43个升高、12个降低)。
  • ELISA验证队列共50例:13例健康对照、15例继发性血小板减少对照、22例ITP患儿。
  • 与对照队列相比,ITP受试者血浆MMP-9水平显著升高、血浆THBS1浓度降低。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 作者指出MMP-9和THBS1作为诊断ITP生物标志物的潜在作用尚需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To use proteomic techniques to identify sensitive diagnostic biomarkers for paediatric immune thrombocytopenia (ITP). We selected children in ITP and control groups, using a four-dimensional data-independent acquisition approach (4D-DIA) to analyse its protein expression. The significantly differentially expressed proteins were selected for enzyme-linked immunosorbent assay (ELISA) validation in a cohort comprising 50 samples (13 healthy controls, 15 secondary thrombocytopenia controls and 22 children with ITP). Receiver operating characteristics (ROC) were generated to diagnose ITP and to assess the diagnostic effectiveness of this approach. Compared with the control group, 55 differentially expressed proteins (43 increased and 12 decreased) were determined in the ITP group. Matrix metalloproteinases-9 (MMP-9) and thrombospondin-1 (THBS1) were significantly expressed and selected for ELISA. The verification outcomes aligned with the findings from the proteomic examinations. In contrast to the control cohort, the ITP subjects exhibited markedly elevated plasma MMP-9 levels and reduced plasma THBS1 concentrations. Additionally, the ROC curves indicated the diagnostic value of these biomarkers. In conclusion, proteomics facilitates identifying the sensitive biomarkers for ITP diagnosis. We have preliminarily selected two differentially expressed proteins, MMP-9 and THBS1, whose potential role as biomarkers for diagnosing ITP requires further research.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Xu W, Wang Y, Cao Q, et al. Study on diagnostic-sensitive markers of primary immune thrombocytopenia in children based on plasma proteomics. Br J Haematol. 2024. PMID: 39189043. doi:10.1111/bjh.19730

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。